These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38533156)

  • 1. Bidirectional ABO Mismatch Is Associated With Elevated Mortality in Hematopoietic Stem Cell Transplantation: Insights From a Single-Center Experience.
    Özkan SG; Kimiaei A; Safaei S; Büyükyatıkçı AA; Sönmezoğlu M; Özkan HA
    Cureus; 2024 Feb; 16(2):e54847. PubMed ID: 38533156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of ABO incompatibility in allogeneic hematopoietic stem cell transplantation.
    Ataca Atilla P; Akkus E; Atilla E; Gokmen N; Civriz Bozdag S; Kocak Toprak S; Kurt Yuksel M; Ozcan M; Demirer T; Ilhan O; Beksac M; Akan H; Arslan O; Topcuoglu P; Gurman G
    Transfus Clin Biol; 2020 Aug; 27(3):115-121. PubMed ID: 32659269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment pure red cell aplasia after ABO major mismatched allogeneic hematopoietic stem cell transplantation with avatrombopag and low dose rituximab.
    Cao J; Lu S; Luo D; Pei R; Lu Y; Chen D; Du X; Li S
    Transfusion; 2024 Mar; 64(3):510-516. PubMed ID: 38351735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor-to-Recipient ABO Mismatch Does Not Impact Outcomes of Allogeneic Hematopoietic Cell Transplantation Regardless of Graft Source.
    Damodar S; Shanley R; MacMillan M; Ustun C; Weisdorf D
    Biol Blood Marrow Transplant; 2017 May; 23(5):795-804. PubMed ID: 28232088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of ABO-incompatible donor on early and late outcome of hematopoietic stem cell transplantation.
    Ozkurt ZN; Yegin ZA; Yenicesu I; Aki SZ; Yagci M; Sucak GT
    Transplant Proc; 2009 Nov; 41(9):3851-8. PubMed ID: 19917400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ABO blood group incompatibility as an adverse risk factor for outcomes in patients with myelodysplastic syndromes and acute myeloid leukemia undergoing HLA-matched peripheral blood hematopoietic cell transplantation after reduced-intensity conditioning.
    Hefazi M; Litzow M; Hogan W; Gastineau D; Jacob E; Damlaj M; Hashmi S; Al-Kali A; Patnaik MM
    Transfusion; 2016 Feb; 56(2):518-27. PubMed ID: 26446051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic peripheral blood stem cell transplantation using reduced-intensity conditioning in an outpatient setting in ABO-incompatible patients: are survival and graft-versus-host disease different?
    Gutiérrez-Aguirre CH; Gómez-De-León A; Alatorre-Ricardo J; Cantú-Rodríguez OG; González-Llano O; Jaime-Pérez JC; Mancías-Guerra C; Flores-Jiménez JA; Gómez-Almaguer D
    Transfusion; 2014 May; 54(5):1269-77. PubMed ID: 24898453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is ABO mismatch another risk factor for allogeneic hematopoietic stem cell transplantation in pediatric thalassemic patients?
    Atay D; Erbey F; Akcay A; Ozturk G
    Pediatr Transplant; 2015 Sep; 19(6):645-51. PubMed ID: 26156679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of ABO blood group incompatibility on the outcomes of allogeneic hematopoietic stem cell transplantation.
    Ciftciler R; Goker H; Buyukasık Y; Karaagac T; Aksu S; Tekin F; Demiroglu H
    Transfus Apher Sci; 2020 Feb; 59(1):102597. PubMed ID: 31311753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of Pure Red Cell Aplasia Following Major ABO-Incompatible Hematopoietic Stem Cell Transplantation.
    Zhu P; Wu Y; Cui D; Shi J; Yu J; Zhao Y; Lai X; Liu L; Xie J; Huang H; Luo Y
    Front Immunol; 2022; 13():829670. PubMed ID: 35222414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immuno-hematological monitoring after allogeneic stem cell transplantation: a single-center, prospective study of 104 patients.
    La Rocca U; Barberi W; Di Rocco A; Giovannetti G; Neri A; Santilio I; Carmini D; Quattrocchi L; Gozzer M; Bafti MS; Ricci R; Girelli G; Foà R; Iori AP; Coluzzi S
    Blood Transfus; 2022 Sep; 20(5):404-413. PubMed ID: 35543676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Major ABO-incompatible hematopoietic stem cell transplantation: study of post-transplant pure red cell aplasia and endothelial cell chimerism.
    Mueller RJ; Stussi G; Odermatt B; Halter J; Schanz U; Seebach JD
    Xenotransplantation; 2006 Mar; 13(2):126-32. PubMed ID: 16623806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of ABO-Incompatibility on Outcome of Allogeneic Hematopoietic Stem Cell Transplantation].
    Yang BB; Gan YF; Chen P; Chen Y; Yu K
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):535-540. PubMed ID: 28446307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pure red cell aplasia following ABO-incompatible allogeneic hematopoietic stem cell transplantation].
    Fan H; Jing Y; Li HH; Lu XC; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):364-7. PubMed ID: 18426666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of pure red cell aplasia after major or bidirectional ABO blood group incompatible hematopoietic stem cell transplantation by pretransplant reduction of host anti-donor isoagglutinins.
    Stussi G; Halter J; Bucheli E; Valli PV; Seebach L; Gmür J; Gratwohl A; Schanz U; Passweg JR; Seebach JD
    Haematologica; 2009 Feb; 94(2):239-48. PubMed ID: 19144657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemolysis, pure red cell aplasia and red cell antibody formation associated with major and bidirectional ABO incompatible haematopoietic stem cell transplantation.
    Tomac G; Bojanić I; Mazić S; Vidović I; Raos M; Ćepulić BG; Seiwerth RS; Kelečić J; Labar B
    Blood Transfus; 2018 Jul; 16(4):397-404. PubMed ID: 28488966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Donor-to-Recipient ABO Mismatch on Outcomes of Antithymocyte Globulin-Based Peripheral Blood Stem Cell-Derived Myeloablative Conditioning Haploidentical Stem Cell Transplantation.
    Wu Y; Ni L; Liu Y; Yang L; Zhu P; Shi J; Wu Z; Zhao Y; Yu J; Lai X; Liu L; Fu H; Xie J; Huang H; Luo Y
    Transplant Cell Ther; 2022 Jun; 28(6):331.e1-331.e10. PubMed ID: 35231641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consequences of ABO incompatibility in multiple myeloma patients undergoing peripheral blood stem cell transplantation after reduced intensity conditioning.
    Marenchino D; Maddalena L; Balbo R; Avonto I; Menardi G; Prucca M; Perotti L; Mordini N; Peano G
    Blood Transfus; 2011 Jan; 9(1):79-85. PubMed ID: 21084015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective study to assess the impact of ABO incompatibility on outcomes of allogeneic peripheral blood stem cell transplants at a tertiary care hospital in Western Maharashtra.
    Nalukettil BB; Biswas AK; Asthana B; Kushwaha N; Baranwal AK; Sharma S
    Asian J Transfus Sci; 2023; 17(2):202-209. PubMed ID: 38274976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of a pure red cell aplasia patient following ABO-mismatched hematopoietic stem cell transplantation from a sibling donor with multiple sclerosis.
    Tavakoli F; Mohammadian M; Ghorbi MD; Shahsavan S; Halvachi D; Parkhideh S; Roshandel E
    Transpl Immunol; 2023 Aug; 79():101863. PubMed ID: 37236515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.